NIPER Raebareli and Roche Pharma India Partner to Strengthen Pharmaceutical Education and Research

manufacturing-news
Image Courtesy: Pixabay

Roche Pharma India has entered into a strategic collaboration with the National Institute of Pharmaceutical Education and Research (NIPER) Raebareli to enhance academic–industry engagement and strengthen capabilities in pharmaceutical education and research. The partnership was formalised through a Memorandum of Understanding signed at the Department of Pharmaceuticals in the presence of senior government officials.

The collaboration is designed to bridge the gap between academic training and industry requirements by equipping students and faculty with practical exposure to evolving pharmaceutical practices, regulatory frameworks, and emerging technologies. The initiative reflects a growing emphasis on aligning education with real-world healthcare and biopharmaceutical challenges.

As part of the agreement, a series of joint programmes will be introduced, including a certificate course in regulatory affairs aimed at students and working professionals. The collaboration will also feature guest lectures delivered by industry experts, focusing on areas such as artificial intelligence in drug development, pharmaceutical research, and healthcare innovation.

Students at NIPER Raebareli will have access to scholarship-linked industry exposure opportunities through Roche’s LEAP programme, enabling hands-on learning and professional development. In addition, faculty immersion initiatives will provide educators with direct exposure to industry practices, helping strengthen curriculum relevance and teaching methodologies.

Officials present at the signing highlighted the importance of building expertise in areas such as regulatory science, biologics, and digital technologies to enhance India’s competitiveness in the global pharmaceutical sector. The partnership is expected to contribute to developing a skilled workforce capable of supporting innovation and advancing healthcare outcomes.

Both organisations indicated that the collaboration will play a role in supporting India’s transition toward a more innovation-driven biopharmaceutical ecosystem. By combining academic excellence with industry insights, the initiative aims to foster research, encourage innovation, and prepare future-ready professionals.

This partnership builds on Roche Pharma India’s ongoing engagement with academic institutions. Earlier in 2026, the company signed a similar agreement with NIPER Mohali, focusing on curriculum development, mentorship, and industry-oriented training programmes.

NIPER Raebareli, as a leading institute for pharmaceutical education, continues to expand its focus on research-led learning and industry collaboration. The institute aims to equip students with the skills required to address global healthcare challenges while contributing to India’s growing role in the biopharmaceutical sector.

Roche Products (India) Private Limited was established in 1994 as a wholly owned subsidiary of the Roche Group, headquartered in Basel, Switzerland. The Roche Group is a global biotechnology leader, recognized for its innovative medicines across key therapeutic areas including oncology, immunology, infectious diseases, ophthalmology and disorders of the central nervous system.